Download PDF
Thromb Haemost 1984; 51(02): 254-256
DOI: 10.1055/s-0038-1661070
Original Article
Schattauer GmbH Stuttgart

High and Low Affinity Heparin Compared with Unfractionated Heparin as Antithrombotic Drugs

R E Merton
The National Institute for Biological Standards and Control, Holly Hill, Hampstead, London, U. K.
,
D P Thomas
The National Institute for Biological Standards and Control, Holly Hill, Hampstead, London, U. K.
,
S J Havercroft
The National Institute for Biological Standards and Control, Holly Hill, Hampstead, London, U. K.
,
T W Barrowcliffe
The National Institute for Biological Standards and Control, Holly Hill, Hampstead, London, U. K.
,
U Lindahl
*   The Department of Medical and Physiological Chemistry, Swedish University of Agricultural Sciences, The Biomedical Centre, Uppsala, Sweden
› Author Affiliations
Further Information

Publication History

Received 10 January 1984

Accepted 20 February 1984

Publication Date:
19 July 2018 (online)

Also available at
  PDF Download  Permissions and Reprints

Summary

A preparation of heparin was separated by affinity chromatography into two fractions: one of high (HAH) and the other of low (LAH) affinity to antithrombin III. These two fractions were compared with unfractionated heparin (UFH) by in vitro assay and their ability to impair experimental stasis thrombosis was also examined. Although the in vitro activity of HAH was double that of UFH, HAH was less effective than UFH as an antithrombotic drug; LAH was virtually inactive, both in vitro and in vivo. A mixture of 30 μg/kg of HAH and 50 μg/kg of LAH was as effective in preventing thrombosis as 80 μg/kg of UFH, and was more effective than 40 μg/kg of HAH alone, demonstrating that LAH potentiates the action of HAH in vivo.

Keywords

High affinity heparin - Low affinity heparin - Venous thrombosis
 

  • References

  • 1 Björk I, Lindahl U. Mechanism of the anticoagulant action of heparin. Mol Cell Biochem 1982; 48: 161-182
    CrossrefPubMedGoogle Scholar
  • 2 Thomas DP, Merton RE, Barrowcliffe TW, Thunberg L, Lindahl U. Effects of heparin oligosaccharides with high affinity for antithrombin III in experimental venous thrombosis. Thromb Haemostas 1982; 47: 244-248
    PubMedGoogle Scholar
  • 3 Holmer E, Mattsson C, Nilsson S. Anticoagulant and antithrombotic effects of heparin and low molecular heparin fragments in rabbits. Thromb Res 1982; 25: 475-485
    CrossrefPubMedGoogle Scholar
  • 4 Ockleford PA, Carter CJ, Mitchell L, Hirsh J. Discordance between the anti-X activity and the antithrombotic activity of an ultra-low molecular weight heparin fraction. Thromb Res 1982; 28: 401-409
    CrossrefPubMedGoogle Scholar
  • 5 Ockleford PA, Carter CJ, Cerkus A, Smith CA, Hirsh J. Comparison of the in vivo haemorrhagic effects and antithrombotic effects of a low antithrombin III affinity heparin fraction. Thromb Res 1982; 27: 679-690
    CrossrefPubMedGoogle Scholar
  • 6 Höök M, Björk I, Hopwood I, Lindahl U. Anticoagulant activity of heparin: separation of high-activity and low-activity heparin species by affinity chromatography on immobilized antithrombin. FEBS Letts 1976; 66: 90-93
    CrossrefPubMedGoogle Scholar
  • 7 Thomas DP, Merton RE, Lewis WE, Barrowcliffe TW. Studies in man and experimental animals of a low molecular weight heparin fraction. Thromb Haemostas 1981; 45: 214-218
    PubMedGoogle Scholar
  • 8 Wessler S, Reimer SM, Sheps MC. Biologic assay of a thrombosis inducing ability in human serum. J Appl Physiol 1959; 14: 943-946
    CrossrefPubMedGoogle Scholar
  • 9 Lane DA, MacGregor IR, Michalski R, Kakkar VV. Anticoagulant activities of four unfractionated and fractionated heparins. Thromb Res 1978; 12: 257-271
    CrossrefPubMedGoogle Scholar
  • 10 Barrowcliffe TW, Johnson EA, Eggleton CA, Kemball-Cook. Thomas DP. Anticoagulant activities of high and low molecular weight heparin fractions. Br J Haematol 1979; 41: 573-583
    CrossrefPubMedGoogle Scholar
  • 11 Kakkar VV, Djazaeri B, Fok J, Fletcher M, Scully MF, Westwick J. Low molecular weight heparin and prevention of postoperative deep vein thrombosis. Br Med J 1982; 284: 375-379
    CrossrefPubMedGoogle Scholar
  • 12 Thomas DP, Merton RE. A low molecular weight heparin compared with unfractionated heparin. Thromb Res 1982; 28: 343-350
    CrossrefPubMedGoogle Scholar
  • 13 Andersson LO, Barrowcliffe TW, Holmer E, Johnson EA, Sims GE. Anticoagulant properties of heparin fractionated by affinity chromatography on matrix-bound antithrombin III and by gel filtration. Thromb Res 1976; 9: 575-583
    CrossrefPubMedGoogle Scholar
  • 14 Wessler S, Morris LE. Studies in intravascular coagulation. IV: The effect of heparin and dicumarol on serum-induced venous thrombosis. Circulation 1955; 12: 553-556
    CrossrefPubMedGoogle Scholar
  • 15 Barrowcliffe TW, Merton RE, Havercroft SJ, Thunberg L, Lindahl U, Thomas DP. Low-affinity heparin potentiates the action of high- affinity heparin oligosaccharides. Thromb Res. 1984 (in press)
    PubMedGoogle Scholar